306739-85-5

Basic information

• Product Name: 2-[(R)-1-((E)-1,2-dichlorovinyloxy)ethyl]-1,3,5-triisopropylbenzene
• Synonyms: 2-[(R)-1-((E)-1,2-dichlorovinyloxy)ethyl]-1,3,5-triisopropylbenzene
• CAS NO: 306739-85-5
• Molecular Weight: 343.337
• Mol File: 306739-85-5.mol

Chemical Properties

• CAS DataBase Reference: 2-[(R)-1-((E)-1,2-dichlorovinyloxy)ethyl]-1,3,5-triisopropylbenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(R)-1-((E)-1,2-dichlorovinyloxy)ethyl]-1,3,5-triisopropylbenzene(306739-85-5)
• EPA Substance Registry System: 2-[(R)-1-((E)-1,2-dichlorovinyloxy)ethyl]-1,3,5-triisopropylbenzene(306739-85-5)

Safety Data

• Hazardous Substances Data: 306739-85-5(Hazardous Substances Data)

Upstream product

• 79-01-6 Trichloroethylene 
• 181531-14-6 (R)-(+)-1-(2,4,6-triisopropylphenyl)ethanol 

Downstream Products

• 1357378-25-6 (R,Z)-3-(1-(2,4,6-triisopropylphenyl)ethoxy)prop-2-en-1-ol 
• 1013657-45-8 (2R,3S)-2-(benzyloxymethyl)-3-((R)-1-(2,4,6-triisopropylphenyl)ethoxy)cyclobutanone 
• 1357378-33-6 (2R,3S)-3-((R)-1-(2,4,6-triisopropylphenyl)ethoxy)-2-((triisopropylsilyloxy)methyl)cyclobutanone 
• 1357378-32-5 (2R,3S)-2-allyl-3-((R)-1-(2,4,6-triisopropylphenyl)ethoxy)cyclobutanone 
• 1357378-28-9 (R,E)-2-(1-(3-(benzyloxy)prop-1-enyloxy)ethyl)-1,3,5-triisopropylbenzene 
• 1357378-27-8 (R,E)-triisopropyl(3-(1-(2,4,6-triisopropylphenyl)ethoxy)allyloxy)silane 
• 1357378-29-0 (R,E)-3-(1-(2,4,6-triisopropylphenyl)ethoxy)prop-2-en-1-ol 
• 1357378-26-7 (R,E)-1,3,5-triisopropyl-2-(1-(penta-1,4-dienyloxy)ethyl)benzene 
• 1166871-15-3 C₂₄H₃₄Cl₂O₂ 
• 1030594-09-2 (R,Z)-2-(1-(3-(benzyloxy)prop-1-enyloxy)ethyl)-1,3,5-triisopropylbenzene 
• 1030594-67-2 (R,Z)-triisopropyl(3-(1-(2,4,6-triisopropylphenyl)ethoxy)allyloxy)silane 

Relevant articles and documents

Highly Enantioselective Approach to Indolizidines: Preparation of (+)-(1S,8aS)-1-Hydroxyindolizidine and (-)-Slaframine

A highly stereoselective approach to (-)-slaframine and its probable biosynthetic precursor (+)-(1S,8aS)-1-hydroxyindolizidine has been developed based on a diastereofacially selective cycloaddition of dichloroketene with a chiral dienol ether.